Financial forecasts are of particular interest to investors and stakeholders. This type of knowledge informs buyers and stakeholders of the...
Reports
Pivotal Phase III study in patients with severe dermatological condition bullous pemphigoid (BP) planned to start H1 2021 following successful...
HOUSTON--(BUSINESS WIRE)--Nov 30, 2020-- Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND ®...